Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial

Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center’s status, along with a version update from 3.4.0 to 3.4.1, were added.
    Difference
    0.4%
    Check dated 2026-02-04T00:23:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A glossary display was added to improve understanding of terms on the study page. In addition, there are minor text and version updates (new QC criteria label and Revision: v3.4.0) and removal of similar old labels.
    Difference
    0.2%
    Check dated 2026-01-27T23:56:23.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision notice was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:51:41.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now includes a Locations section with North Holland (Amsterdam UMC, location VUmc); the old North Holland Locations header was removed and the footer HHS Vulnerability Disclosure link was removed, with revision tag updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:22:32.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The additions include an automated PubMed publications note and a revision tag (Revision: v3.3.2). The deletions remove the older PubMed note and the previous revision tag (Revision: v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T21:06:42.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Removed the funding-status notice that warned about potential delays in updating information due to government funding. This does not modify the study details, eligibility criteria, or outcomes listed on the page.
    Difference
    0.3%
    Check dated 2025-11-17T18:24:17.000Z thumbnail image

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.